Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy in Vietnam
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-6
SponsorNational Children's Hospital, Vietnam
About this trial
This study aims to evaluate the effectiveness of therapeutic hypothermia in neonates diagnosed with hypoxic-ischemic encephalopathy (HIE). The study focuses on assessing both short-term outcomes after treatment and long-term neurological outcomes following therapeutic hypothermia.
Eligibility criteria
Qualifiers
Neonates diagnosed with hypoxic-ischemic encephalopathy (HIE) at the Neonatal Center, National Children's Hospital
Gestational age ≥ 36 weeks
Assessed using the modified Sarnat staging within the first 0-6 hours after birth
Eligible for and/or treated with therapeutic hypothermia according to institutional protocol
Disqualifiers
Presence of major congenital anomalies, particularly involving the central nervous system
Absence of brain MRI during the study period
Refusal of participation by parent(s) or legal guardian(s)
Trial design
Treatments tested in this trial
- Therapeutic Hypothermia
Treatment groups
120 Participants
are divided into 1 treatment groupLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Vietnam National Children's HospitalvRecruiting111111, Ha Nội, Hanoi
Vietnam
VietnamSponsors and collaborators
Source ClinicalTrials.gov